NASDAQ:ASMB - Assembly Biosciences Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$41.18 -1.58 (-3.70 %)
(As of 07/19/2018 04:00 PM ET)
Previous Close$42.76
Today's Range$40.86 - $42.75
52-Week Range$20.75 - $67.36
Volume256,333 shs
Average Volume207,872 shs
Market Capitalization$894.98 million
P/E Ratio-17.09
Dividend YieldN/A
Beta0.75

Analyst Ratings

Assembly Biosciences (NASDAQ:ASMB) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Assembly Biosciences in the last 12 months. Their average twelve-month price target is $56.6667, suggesting that the stock has a possible upside of 37.61%. The high price target for ASMB is $75.00 and the low price target for ASMB is $45.00. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldBuy
Consensus Rating Score: 2.332.332.332.67
Ratings Breakdown: 0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
2 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $56.6667$56.6667$53.3333$40.00
Price Target Upside: 37.61% upside27.97% upside9.81% upside10.93% downside

Assembly Biosciences (NASDAQ:ASMB) Consensus Price Target History

Price Target History for Assembly Biosciences (NASDAQ:ASMB)

Assembly Biosciences (NASDAQ:ASMB) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/8/2018B. RileyLower Price TargetNeutral ➝ Neutral$45.00HighView Rating Details
4/13/2018Chardan CapitalDowngradeBuy ➝ Neutral$35.00 ➝ $50.00HighView Rating Details
3/8/2018Jefferies Financial GroupBoost Price TargetBuy$75.00MediumView Rating Details
8/19/2016William BlairInitiated CoverageMarket Perform ➝ OutperformN/AView Rating Details
(Data available from 7/19/2016 forward)
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Featured Article: Short Selling

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.